Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222716 · ClinicalTrials.gov registry record · NA
Managing Medications
A NA study of HIV Infections, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 349
- Enrollment target
- 1
- Study location
NCT00222716: Completed NA study of HIV Infections, sponsored by University of Pittsburgh.
NCT00222716 is a NA study of HIV Infections that has completed, run by University of Pittsburgh. The registered enrollment target is 349 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00222716, a NA study of HIV Infections, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 349 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to compare the effect of an individualized adherence intervention (TI) and a structured adherence intervention (TS) to usual care on adherence to antiretroviral therapy in persons infected with HIV (PWHIV).
Primary Outcome
MEMS data using AARDEX medication monitoring caps, percent daily dose correct.
Conditions Studied
Interventions
- BEHAVIORAL Problem solving counseling
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2004-01 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00222716 record still lists
NCT00222716 is an interventional study that assigns participants to a tested intervention. The registered 349 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (22% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Problem solving counseling is the first listed.
NCT00222716 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00222716 about?
NCT00222716 is a clinical study titled "Managing Medications". The primary aim of this study is to compare the effect of an individualized adherence intervention (TI) and a structured adherence intervention (TS) to usual care on adherence to antiretroviral therapy in persons infected with HIV (PWHIV).
What is the current status of trial NCT00222716?
This trial is currently completed. It is a NA study. The enrollment target is 349 participants. The study started on 2004-01. Estimated completion is 2009-12.
What conditions does trial NCT00222716 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00222716?
The interventions under investigation include: Problem solving counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00222716?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00222716 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00222716's enrollment target sits among peer trials
349 101st of 542 higher than 442 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia